Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
Compositions comprising tRNA synthetase polypeptides useful for regulating angiogenesis, as well as nucleic acids encoding such tRNA synthetase polypeptides are described. Methods of making and using such compositions are also disclosed.
1. An isolated angiogenic truncated tyrosyl-tRNA synthetase polypeptide comprising a Rossmann fold nucleotide binding domain, wherein the isolated polypeptide is capable of regulating angiogenic vascular endothelial cell function; wherein the polypeptide is selected from the group consisting of:
a polypeptide consisting essentially of amino acid residues 1–364 of SEQ ID NO: 2,
a polypeptide consisting of amino acid residues 1–343 of SEQ ID NO: 2,
a dimer of a polypeptide consisting essentially of amino acid residues 1–364 of SEQ ID NO: 2.
2. The isolated polypeptide of claim 1 wherein the truncated tRNA synthetase polypeptide consists essentially of amino acid residues 1–364 of SEQ ID NO: 2 or a dimer thereof.
3. A composition comprising the isolated polypeptide of claim 1 and a pharmaceutically suitable excipient.
4. A composition comprising the isolated polypeptide of claim 3 and a pharmaceutically suitable excipient.